Scope
Reference
C355337
Description
DHSC is conducting a market engagement exercise to understand more about the companies and services in the UK that can, or that are seeking to produce, distribute, supply and store different formulations of take-home naloxone that can reverse the effect of an opioid overdose. In particular, we are looking to understand how these suppliers and manufacturers could potentially meet the future of needs of a UK Buffer Stock of Naloxone. The outcome of the market engagement will inform decisions around potential future procurement and storage of a naloxone buffer stock as well as providing information on how the market could meet a potential increase in demand across the UK. For the avoidance of doubt, this is not a call for competition, the purpose is to seek feedback from the market that may inform the final specification and or procurement approach to the goods and services. https://health-family.force.com/s/Welcome
Total value (estimated)
- £1,900,000 excluding VAT
- £2,280,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 October 2025 to 31 August 2026
- Possible extension to 31 August 2028
- 2 years, 11 months, 1 day
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
- 33670000 - Medicinal products for the respiratory system
- 33693300 - Addiction treatment
Contract locations
- UK - United Kingdom
Engagement
Engagement deadline
9 May 2025
Engagement process description
Engaging with the market to gather information and insight.
Submission
Publication date of tender notice (estimated)
23 May 2025
Contracting authority
DHSC, London
- Public Procurement Organisation Number: PMQG-9965-CHZR
39 Victoria Street
London
SW1H 0EU
United Kingdom
Contact name: Jackie Jones
Email: ccsinbox@dhsc.gov.uk
Website: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Region: UKI32 - Westminster
Organisation type: Public authority - central government